Загрузка...
Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival
INTRODUCTION: Hepatitis B virus (HBV) reactivation has been reported in B-cell lymphoma patients with resolved hepatitis B (hepatitis B surface antigen [HBsAg]-negative and hepatitis B core antibody [HBcAb]-positive). This study aimed to assess HBV reactivation and hepatitis occurrence in diffuse la...
Сохранить в:
| Опубликовано в: : | Chin J Cancer |
|---|---|
| Главные авторы: | , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4593350/ https://ncbi.nlm.nih.gov/pubmed/26058465 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40880-015-0015-9 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|